Additionally, the achievement of Ozempic in Mexico may pave the way for comparable funds-welcoming options to generally be released in other regions of Health care. BMJ Open 2017: Risk for metabolic conditions in usual weight individuals with visceral fat accumulation: a cross-sectional study in